Elite Health CEO granted 68,421 stock warrants
EHSI’s CEO received a new warrant grant while maintaining over 3.8 million common shares in direct and indirect holdings.
Rhea-AI Filing Summary
Elite Health Systems Inc. (EHSI) reported that CEO, director, and greater-than-10% owner jeereddi Prasad Anjaneya received a grant of 68,421 common stock warrants on August 31, 2026, with an exercise price of $0.95 per share and expiration on August 31, 2031. Following this grant, he holds 178,947 warrants in total. His reported common stock holdings are 3,624,484 shares directly and 225,716 shares indirectly through an entity where he is a managing member and major equity owner. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 68,421 shares
Grant/Award
3 txns
Insider
jeereddi Prasad Anjaneya
Role
CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common stock warants | 68,421 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F1 | -- | -- | -- |
Holdings After Transaction:
Common stock warants — 178,947 contracts (Direct);
Common Stock — 3,624,484 shares (Direct);
Common Stock — 225,716 shares (Indirect, See Footnote)
Footnotes (1)
- F1. Shares held by an entity the Reporting Person is a managing member and major equity owner.
Key Figures
Warrants granted: 68,421 warrants
Warrant exercise price: $0.95 per share
Warrant expiration date: August 31, 2031
+3 more
6 metrics
Warrants granted
68,421 warrants
Grant of common stock warrants on August 31, 2026
Warrant exercise price
$0.95 per share
Exercise price for the 68,421 common stock warrants granted August 31, 2026
Warrant expiration date
August 31, 2031
Expiration for the granted common stock warrants
Total warrants held after grant
178,947 warrants
Total common stock warrants held following the August 31, 2026 grant
Direct common stock holdings
3,624,484 shares
Common Stock directly owned as of August 31, 2026
Indirect common stock holdings
225,716 shares
Common Stock indirectly owned through an entity as of August 31, 2026
Key Terms
Common stock warrants, exercise price, expiration date, indirectly
4 terms
Common stock warrants financial
"received a grant of 68,421 common stock warrants on August 31, 2026"
Common stock warrants are tradable certificates that give the holder the right, but not the obligation, to buy a company’s common shares at a fixed price before a specified expiration date. They work like long-term options issued by the company and can provide cheaper, leveraged exposure to a stock’s potential upside; however, if holders use the warrants to buy shares, the total number of shares increases, which can dilute the value of existing shares.
exercise price financial
"with an exercise price of $0.95 per share and expiration"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"an exercise price of $0.95 per share and expiration on August 31, 2031"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
indirectly financial
"225,716 shares indirectly through an entity where he is a managing"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did EHSI CEO jeereddi Prasad Anjaneya acquire in this Form 4 filing?
He received a grant of 68,421 common stock warrants on August 31, 2026, with an exercise price of $0.95 per share and expiration on August 31, 2031, characterized as a grant, award, or other acquisition.
What are the CEO’s total warrant holdings reported for EHSI in this filing?
After the August 31, 2026 grant, he holds 178,947 common stock warrants in total, each with an exercise price of $0.95 per share and an expiration date of August 31, 2031.
What indirect holdings of EHSI common stock does the CEO report?
He reports 225,716 shares of EHSI common stock held indirectly, with a footnote stating these shares are held by an entity where he is a managing member and major equity owner.
Was the EHSI CEO’s warrant grant made under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not affirmed, and no footnote describes a trading plan, so no Rule 10b5-1 plan is reported for the August 31, 2026 warrant grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
